Changes are being made to the terminology and diagnostic criteria of non-alcoholic fatty liver disease, which may have implications for diagnosis and treatment. The condition is being studied in various populations, including those with chronic hepatitis B and lean individuals, to better understand its characteristics and connections to metabolic dysfunction. Research is also exploring new diagnostic approaches, including the potential role of the gut microbiome in disease progression.